Skip to main content
Medicine logoLink to Medicine
. 2016 Mar 25;95(12):e3196. doi: 10.1097/MD.0000000000003196

Outcomes After Non-neurological Surgery in Patients With Parkinson's Disease

A Nationwide Matched Cohort Study

Yu-Feng Huang 1, Yi-Chun Chou 1, Chun-Chieh Yeh 1, Chaur-Jong Hu 1, Yih-Giun Cherng 1, Ta-Liang Chen 1, Chien-Chang Liao 1
Editor: Kazuo Hanaoka1
PMCID: PMC4998413  PMID: 27015218

Abstract

Patients with Parkinson disease (PD) were known to have increased risk of complications during hospitalization. The purpose of this study is to validate the global features of postoperative adverse outcomes for patients with PD.

Using reimbursement claims from Taiwan's National Health Insurance Research Database, we conducted a nationwide retrospective cohort study of 6455 patients with preoperative PD receiving major surgery during 2008 to 2012. With a propensity score matching procedure, 12,910 surgical patients without PD were selected for comparison. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for 9 major postoperative complications and 30-day postoperative mortality associated with preoperative PD were calculated in the multivariate logistic regressions.

Patients with PD had increased risk of postoperative pulmonary embolism (OR 2.72, 95% CI 1.45–5.10), stroke (OR 1.77, 95% CI 1.53–2.05), pneumonia (OR 1.98, 95% CI 1.70–2.31), urinary tract infection (OR 1.52, 95% CI 1.35–1.70), septicemia (OR 1.54, 95% CI 1.37–1.73), acute renal failure (OR 1.36, 95% CI 1.07–1.73), and mortality (OR 1.45, 95% CI 1.06–1.98). The association between preoperative PD and postoperative adverse events was significant in both sexes and every age group. Low income, ≥65 years of age, surgery not in medical center, highest quartile of PD medication users, and more medical conditions worsen the risk of postoperative adverse events in patients with PD.

This study showed increased postoperative complications and mortality in patients with PD. Our findings suggest that revision of postoperative care protocols for this population is urgently needed.

INTRODUCTION

Parkinson disease (PD) is the second-most common neurodegenerative disorder worldwide, and mainly affects those in the middle to older age groups.1 Approximately 1% of the population aged more than 60 years has PD, which is expected to impose an increasing social and economic burden on societies as populations age.2 The average annual US healthcare cost for patients with PD is more than twice than that of people without PD.3,4 Common motor manifestations of PD include tremor at rest, stiffness (rigidity), slowness of movements (bradykinesia), shuffling steps, and difficulties with balance.5

Previous studies noted increased adverse events such as aspiration pneumonia and urinary tract infection after surgeries in patients with PD.6,7 However, these previous studies were limited by small sample size,6,811 focusing solely on specific types of surgery,711 lack of control group,10,11 inadequate adjustment for potential confounders,6,911 and lack of matching procedure.7,911 In addition, postoperative outcomes in patients with PD were not completely understood.

We conducted a nationwide population-based retrospective cohort study using Taiwan's National Health Insurance Research Database (NHIRD) to investigate the full spectrum of adverse postoperative outcomes, and to analyze the impact of PD severity for patients who underwent major non-neurological surgeries.

METHODS

Data Sources

This study used reimbursement claims data from Taiwan's National Health Insurance program. This universal insurance program started in March 1995, and now covers more than 99% of 22.6 million Taiwan residents. Taiwan's National Health Research Institutes established the NHIRD to record all beneficiaries’ inpatient and outpatient medical services. Information in the database includes patient demographics, primary and secondary disease diagnoses, procedures, prescriptions, and medical expenditures. The validity of this database has been favorably evaluated, and research articles based on it have been accepted in prominent scientific journals worldwide.1218

Ethical Approval

Insurance reimbursement claims used in this study were from Taiwan's NHIRD. This study was conducted in accordance with the Helsinki Declaration. To protect personal privacy, the electronic database was decoded with patient identifications scrambled for further academic access for research. According to National Health Research Institutes regulations, informed consent is not required because of the use of decoded and scrambled patient identifications.1217 However, this study was evaluated and approved by Taiwan's NHIRD-103–121 and the Institutional Review Board of Taipei Medical University (TMU-JIRB-201404070).

Study Design

We examined medical claims and identified 6455 patients aged ≥60 years with preoperative PD (at least 3 visits of medical care with physician's primary diagnosis of PD and PD medications) from 2,023,346 patients who underwent major inpatient surgeries between 2008 and 2012 in Taiwan. These surgeries required general, epidural, or spinal anesthesia and hospitalization for more than 1 day. To identify patients with PD, we required at least 1 visit for outpatient or inpatient medical services, with a neurological physician's diagnosis of PD within the 24-month preoperative period. We matched each surgical patient with PD with 2 randomly selected surgical patients without PD by sex, age, type of surgery, type of anesthesia, coexisting medical conditions, operation in teaching hospital or not, and low income or not, and conducted the analysis with a propensity score-matched pair procedure (case-control ratio = 1:2). The complications, length of hospital stay, medical expenditure, admission to intensive care unit, and mortality within postoperative 30-day period were compared between surgical patients with and without preoperative PD.

Measures and Definitions

We identified income status by defining low-income patients as those qualifying for waived medical copayment, because this status is verified by the Bureau of National Health Insurance. Whether the surgery was performed in a medical center, the time of surgery and the types of surgery and anesthesia were also recorded. We used the “International Classification of Diseases, Ninth Revision, Clinical Modification” (ICD-9-CM) to define preoperative medical diseases and postoperative complications. Preoperative PD (ICD-9-CM 332) was defined as the major exposure. Preexisting medical conditions that were determined from medical claims for the 24-month preoperative period included mental disorders (ICD-9-CM 290–319), hypertension (ICD-9-CM 401–405), diabetes (ICD-9-CM 250), chronic obstructive pulmonary disease (ICD-9-CM 490–496), hyperlipidemia (ICD-9-CM 272.0, 272.1, and 272.2), liver cirrhosis (ICD-9-CM 571), congestive heart failure (ICD-9-CM 428), and atrial fibrillation (427.3). Renal dialysis was defined by administration code (D8, D9). Inhospital 30-day mortality after the index surgery was considered the study's primary outcome. Nine major surgical postoperative complications were noted, including pulmonary embolism (ICD-9-CM 415), stroke (ICD-9-CM 430–438), pneumonia (ICD-9-CM 480–486), urinary tract infection (ICD-9-CM 599.0), septicemia (ICD-9-CM 038, 998.5), acute renal failure (ICD-9-CM 584), postoperative bleeding (ICD-9-CM 998.0, 998.1 and 998.2), acute myocardial infarction (ICD-9-CM 410), and deep wound infection (ICD-9-CM 958.3) after the index surgery. Admission to intensive care unit, length of hospital stay, and medical expenditure after index surgery were analyzed as secondary outcomes.

Statistical Analysis

To reduce confounding errors,12,13,16 this study used a propensity score-matched pair procedure to balance the covariates between surgical patients with and without PD. We developed a nonparsimonious multivariable logistic regression model to estimate a propensity score for preoperative PD. Clinical significance guided the initial choice of covariates in this model: sex, age, operation in medical center or not, low-income status, mental disorders, hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, renal dialysis, liver cirrhosis, congestive heart failure, atrial fibrillation, types of surgery and anesthesia, and time of surgery. A structured iterative approach was used to refine this model with the goal of achieving covariate balance within the matched pairs. We used chi-square tests to measure covariate balance, and P < 0.05 was suggested to represent meaningful covariate imbalance. We matched patients with PD to non-PD patients using a greedy-matching algorithm with a caliper width of 0.2 SD of the log odds of the estimated propensity score. This method could remove 98% of the bias from measured covariates.12,13,16

Adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for 30-day postoperative complications and mortality between patients with and without PD were analyzed with multivariate logistic regression models by controlling for age, sex, operation in medical center, low-income status, mental disorders, hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, renal dialysis, liver cirrhosis, congestive heart failure, atrial fibrillation, types of surgery and anesthesia, and time of surgery. We also performed stratification analysis by age, sex, and coexisting medical conditions for associations between preoperative PD and postoperative adverse events (including 30-day inhospital mortality, pulmonary embolism, stroke, pneumonia, urinary tract infection, and septicemia). The multivariate logistic regression analyses were applied to investigate 30-day postoperative adverse events associated with characteristics of PD after controlling for age, sex, operation in medical center or not, low-income status, mental disorders, hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, renal dialysis, liver cirrhosis, congestive heart failure, atrial fibrillation, types of surgery and anesthesia, and time of surgery. SAS version 9.1 (SAS Institute Inc., Cary, NC) statistical software was used for data analyses; 2-sided P < 0.05 indicated significant differences.

RESULTS

Table 1 shows demographic characteristics of patients with and without preoperative PD who underwent major surgeries. After propensity score matching, there were no significant differences in perioperative characteristics between surgical patients with and without PD, including sex, operation in medical center or not, low-income status, mental disorders, hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, renal dialysis, liver cirrhosis, congestive heart failure, atrial fibrillation, types of surgery and anesthesia, and time of surgery. Patients with PD had higher mean age than non-PD group (73.0 ± 5.1 vs 72.8 ± 5.1 years; P = 0.0340).

TABLE 1.

Characteristics of Surgical Patients With and Without Parkinson Disease

graphic file with name medi-95-e3196-g001.jpg

Compared with surgical patients without PD (Table 2), patients with PD showed higher risks of postoperative complications, including pulmonary embolism (OR 2.72, 95% CI 1.45–5.10), stroke (OR 1.77, 95% CI 1.53–2.05), pneumonia (OR 1.98, 95% CI 1.70–2.31), urinary tract infection (OR 1.52, 95% CI 1.35–1.70), septicemia (OR 1.54, 95% CI 1.37–1.73), acute renal failure (OR 1.36, 95% CI 1.07–1.73), and any adverse events (OR 1.66, 95% CI 1.54–1.80). Preoperative PD was associated with a significant increase in 30-day postoperative mortality (OR 1.45, 95% CI 1.06–1.98). Patients with PD were more likely to be admitted to intensive care units after surgery than those without PD (OR 1.19, 95% CI 1.11–1.28). The means of medical expenditure (3010 ± 4632 vs 2788 ± 4024 US dollars; P = 0.0010) and length of hospital stay (9.5 ± 14.9 vs 8.4 ± 12.5 days; P < 0.0001) were greater in PD patients than in non-PD patients.

TABLE 2.

Risk of Postoperative Complications and Mortality for Surgical Patients with Preoperative Parkinson Disease

graphic file with name medi-95-e3196-g002.jpg

The stratification analysis (Table 3) shows that the association between preoperative PD and postoperative adverse events was significant in women (OR 1.59, 95% CI 1.43–1.78), men (OR 1.74, 95% CI 1.57–1.93), patients aged 60 to 64 (OR 1.83, 95% CI 1.38–2.41), 65 to 59 (OR 2.00, 95% CI 1.64–2.45), 70 to 74 (OR 1.67, 95% CI 1.45–1.91), and 75– to 79 (OR 1.56, 95% CI 1.39–1.74) years. Preoperative PD was associated with postoperative adverse events, whether surgical patients had or did not have mental disorders, hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, or liver cirrhosis. The association between PD and postoperative adverse events was not significant only in surgical patients with renal dialysis, congestive heart failure, and atrial fibrillation.

TABLE 3.

Stratification Analysis of Associations Between Parkinson Disease and Postoperative Adverse Events

graphic file with name medi-95-e3196-g003.jpg

Compared with patients without PD (Table 4), PD patients ≥65 years of age (OR 1.72, 95% CI 1.59–1.86), with low-income status (OR 3.45, 95% CI 2.23–5.32), with surgery not in medical center (OR 1.52, 95% CI 1.36–1.71), with high PD medications (OR 1.88, 95% CI 1.66–2.13), and with high expenditure for PD (OR 1.93, 95% CI 1.70–2.18) had increased risk of postoperative adverse events. Coexisting medical conditions such as diabetes (OR 2.00, 95% CI 1.78–2.25), chronic obstructive pulmonary disease (OR 1.76, 95% CI 1.51–2.04), and mental disorders (OR 1.70, 95% CI 1.53–1.89) worsen the risk of postoperative adverse events in PD patients compared with those without PD.

TABLE 4.

Preoperative Characteristics of Patients With Parkinson's Disease and Risk of 30-Day Postoperative Adverse Events

graphic file with name medi-95-e3196-g004.jpg

DISCUSSION

In this large-scale nationwide population-based study, patients with PD undergoing non-neurological surgery had higher 30-day inhospital mortality compared with those without PD. Higher incidence of postoperative complications in patients with PD included pulmonary embolism, pneumonia, stroke, urinary tract infection, and septicemia after multivariate adjustment. Increased risk of admission to intensive care unit, prolonged length of hospital stay, and increased medical expenditure were also found in surgical patients with PD. Departing from previous studies,611 our novel findings were that advanced age, medical conditions, and heavy PD medication were associated with postoperative adverse events in patients with PD.

Greater age,19 low-income status,20 and level of hospital21 were determinants of perioperative adverse outcomes. To avoid bias when investigating postoperative adverse outcomes in patients with PD, we used multivariate regression models to adjust these sociodemographic characteristics as potential confounding factors. Previous studies from our database have revealed that diabetes,12 stroke,13 heart failure,22 atrial fibrillation,23 liver cirrhosis,14 renal dialysis,24 chronic obstructive pulmonary disease,25 and mental disorders15 were noted as risk factors of perioperative complications and mortality. Some of these coexisting medical conditions were also considered as comorbidities for patients with PD.26,27 By adjusting for the potential confounding factors, this study found increased postoperative adverse events in patients with PD.

Increased postoperative pneumonia and urinary tract infection in patients with PD had been reported in previous studies,6,7 and this phenomenon was also found in this study. In patients with advanced PD, dysphagia and poor control of the respiratory musculature can result in atelectasis, reduced cough, and saliva accumulation.28,29 Restrictive changes in lungs mainly secondary to chest wall rigidity and upper airway obstruction may present in patients with PD.30 It is plausible that these patients are at increased risk for pneumonia after operations.31 Preoperative assessment of respiratory function and postoperative chest physiotherapy may be warranted to reduce the incidence of pneumonia. Minimizing the interruption of oral anti-Parkinsonism medication during the perioperative period could help to improve respiratory function.32 Urinary tract infection—another infectious complication—can be attributed to PD-related bladder dysfunction that can cause multiple urinary symptoms including urgency, frequency, nocturia, and urinary retention.33 Frequent bladder scans to check for retention and higher vigilance in monitoring for urinary infection may be useful to avoid urinary tract infection and treat it as promptly as possible.

In this investigation, we found significant increases in postoperative pulmonary embolism and stroke in patients with PD; to our knowledge, these findings have never been documented in previous studies. After surgery, the musculoskeletal problems involved in PD make these patients more vulnerable to reduced mobility than the non-PD population.34 Since immobilization is a major risk factor for pulmonary embolism, it is reasonable to postulate that this increased risk in PD patients may relate to prolonged bed rest. Autonomic dysfunction is a common nonmotor symptom of PD35 that may present as orthostatic hypotension and cause fluctuations in blood pressure because of impaired baroreceptor activity during the perioperative period.29 Both of these conditions may lead to more possibility of acute stroke in surgical patients with PD. Because neuropsychiatric disturbances such as cognitive impairment and depression are also frequent nonmotor symptoms in PD,35,36 neurological deficits resulting from stroke may be easily missed by healthcare providers. Frequent blood pressure checks and early recognition of stroke symptoms could be encouraged to better avoid and manage this devastating postoperative complication.

In terms of increased 30-day inhospital mortality, length of hospital stay, and medical expenditure, there are several possible explanations why patients with PD had worse outcomes. First, anti-Parkinsonism oral medication schedules are difficult to maintain during the perioperative period, so exacerbation of PD symptoms is likely.29 The aggravating condition of PD may lead to immobility, which can accompany many fatal outcomes such as pulmonary embolism,37 infection,34 and pressure ulcer.16 Second, neuropsychiatric disturbances, including cognitive impairment, depression, and hallucinations, are not uncommon in patients with PD.35,36 These complex clinical problems can delay recovery during acute care services and increase postoperative complications.15,17 Third, the increased risk of major adverse events such as stroke and pneumonia noted in this study can predispose patients with PD to higher mortality rates. To improve surgical outcomes in patients with PD, healthcare teams should optimize perioperative care by managing these specific issues according to updated guidelines.

In the subgroup analysis, the ORs of 30-day inhospital adverse events in PD patients with some coexisting medical conditions were lower than those without such comorbidities as renal dialysis and heart failure. This can be attributed to the harmful effects of those comorbidities, which decreased the influence on postoperative adverse events from PD itself. The association between PD and risk of postoperative adverse event was similar in patients with and without diabetes in this study. Although the potential link between PD and diabetes remains controversial, recent studies have demonstrated these 2 chronic diseases share similarly dysregulated molecular pathways.38

Further analysis in patients with PD revealed that preoperative intensive rehabilitation and higher intake of and expenditure on PD medication were associated with higher risks of postoperative adverse events. These findings might indirectly reflect the detrimental effects from disease severity, since it was shown that disease severity was correlated with patient expenditure.39 In addition, the present study found that postoperative adverse events increased in PD patients with higher preoperative medical expenditure, more preoperative emergency visits, or more inpatient care. These 3 medical characteristics might be considered indicators of poor general physical or medical status that lead to increased postoperative adverse events.

Although the present study has strengths of large sample size, adjustment for potential confounding factors, analyzing all types of non-neurological surgery, and not being restricted by specific patient groups, there are some limitations common to research based on secondary data. First, detailed information on sociodemographic factors and lifestyles correlating with the postoperative complications or PD was not available from reimbursement claims data. Nor did the database contain patients’ records from physical and laboratory examinations. Second, severity and disability levels of PD could not be obtained in the administrative data for stratification of perioperative risks. Third, even though the accuracy of major diagnosis codes from the NHIRD has been accepted by peer reviewers of scientific journals,12,13,1518 the validity of PD, comorbidity, and complication codes employed in this study might still be a concern. To reduce the possibility of misdiagnosis or miscoding, we used the inclusion criteria of at least 3 visits for medical care with physician's primary diagnosis of PD.

In conclusion, this nationwide population-based study showed that patients with PD undergoing non-neurological surgery have higher 30-day mortality and more common postoperative major complications, including pulmonary embolism, stroke, pneumonia, septicemia, acute renal failure, and urinary tract infection. These findings can improve our understanding of these perioperative issues, and also can help healthcare providers to develop specific protocols to minimize complications and hospital stays in surgical patients with PD.

Footnotes

Abbreviations: ICD-9-CM = International Classification of Diseases, 9th Revision, Clinical Modification, CI = confidence interval, OR = odds ratio, PD = Parkinson disease.

Y-GC has equal contribution with the first author; T-LC has equal contribution with the corresponding author.

Funding: This research was supported in part by Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), and Taiwan's Ministry of Science and Technology (MOST104-2314-B-038-027-MY2; NSC102-2314-B-038-021-MY3).

Disclosure: This study is based in part on data from the NHIRD provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare, or National Health Research Institutes.

The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

The authors have no conflicts of interest to disclose.

REFERENCES

  • 1.Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med 2003; 348:1356–1364. [DOI] [PubMed] [Google Scholar]
  • 2.De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5:525–535. [DOI] [PubMed] [Google Scholar]
  • 3.Okun MS. Deep-brain stimulation for Parkinson's disease. N Engl J Med 2012; 367:1529–1538. [DOI] [PubMed] [Google Scholar]
  • 4.Huse DM, Schulman K, Orsini L, et al. Burden of illness in Parkinson's disease. Mov Disord 2005; 20:1449–1454. [DOI] [PubMed] [Google Scholar]
  • 5.Burch D, Sheerin F. Parkinson's disease. Lancet 2005; 365:622–627. [DOI] [PubMed] [Google Scholar]
  • 6.Mueller MC, Juptner U, Wuellner U, et al. Parkinson's disease influences the perioperative risk profile in surgery. Langenbecks Arch Surg 2009; 394:511–515. [DOI] [PubMed] [Google Scholar]
  • 7.Pepper PV, Goldstein MK. Postoperative complications in Parkinson's disease. J Am Geriatr Soc 1999; 47:967–972. [DOI] [PubMed] [Google Scholar]
  • 8.Jamsen E, Puolakka T, Peltola M, et al. Surgical outcomes of primary hip and knee replacements in patients with Parkinson's disease: a nationwide registry-based case-controlled study. Bone Joint J 2014; 96-B:486–491. [DOI] [PubMed] [Google Scholar]
  • 9.Karadsheh MS, Weaver M, Rodriguez K, et al. Mortality and revision surgery are increased in patients with Parkinson's disease and fractures of the femoral neck. Clin Orthop Relat Res 2015; 473:3272–3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mehta S, Vankleunen JP, Booth RE, et al. Total knee arthroplasty in patients with Parkinson's disease: impact of early postoperative neurologic intervention. Am J Orthop 2008; 37:513–516. [PubMed] [Google Scholar]
  • 11.Weber M, Cabanela ME, Sim FH, et al. Total hip replacement in patients with Parkinson's disease. Int Orthop 2002; 26:66–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yeh CC, Liao CC, Chang YC, et al. Adverse outcomes after noncardiac surgery in patients with diabetes: a nationwide population-based retrospective cohort study. Diabetes Care 2013; 36:3216–3221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liao CC, Chang PY, Yeh CC, et al. Outcomes after surgery in patients with previous stroke. Br J Surg 2014; 101:1616–1622. [DOI] [PubMed] [Google Scholar]
  • 14.Lin CS, Lin SY, Chang CC, et al. Postoperative adverse outcomes after non-hepatic surgery in patients with liver cirrhosis. Br J Surg 2013; 100:1784–1790. [DOI] [PubMed] [Google Scholar]
  • 15.Liao CC, Shen WW, Chang CC, et al. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg 2013; 257:433–438. [DOI] [PubMed] [Google Scholar]
  • 16.Chou CL, Lee WR, Yeh CC, et al. Adverse outcomes after major surgery in patients with pressure ulcer: a nationwide population-based retrospective cohort study. PLoS One 2015; 10:e0127731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hu CJ, Liao CC, Chang CC, et al. Postoperative adverse outcomes in surgical patients with dementia: a retrospective cohort study. World J Surg 2012; 36:2051–2058. [DOI] [PubMed] [Google Scholar]
  • 18.Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20:236–242. [DOI] [PubMed] [Google Scholar]
  • 19.Afshar AH, Virk N, Porhomayon J, et al. The validity of the VA surgical risk tool in predicting postoperative mortality among octogenarians. Am J Surg 2015; 209:274–279. [DOI] [PubMed] [Google Scholar]
  • 20.Dik VK, Aarts MJ, Van Grevenstein WM, et al. Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer. Br J Surg 2014; 101:1173–1182. [DOI] [PubMed] [Google Scholar]
  • 21.Leonard D, Penninckx F, Kartheuser A, et al. Effect of hospital volume on quality of care and outcome after rectal cancer surgery. Br J Surg 2014; 101:1475–1482. [DOI] [PubMed] [Google Scholar]
  • 22.Maile MD, Engoren MC, Tremper KK, et al. Worsening preoperative heart failure is associated with mortality and noncardiac complications, but not myocardial infarction after noncardiac surgery: a retrospective cohort study. Anesth Analg 2014; 119:522–532. [DOI] [PubMed] [Google Scholar]
  • 23.Attaran S, Shaw M, Bond L, et al. A comparison of outcome in patients with preoperative atrial fibrillation and patients in sinus rhythm. Ann Thorac Surg 2011; 92:1391–1395. [DOI] [PubMed] [Google Scholar]
  • 24.Gajdos C, Hawn MT, Kile D, et al. Risk of major nonemergent inpatient general surgical procedures in patients on long-term dialysis. JAMA Surg 2013; 148:137–143. [DOI] [PubMed] [Google Scholar]
  • 25.Gupta H, Ramanan B, Gupta PK, et al. Impact of COPD on postoperative outcomes: results from a national database. Chest 2013; 143:1599–1606. [DOI] [PubMed] [Google Scholar]
  • 26.Leibson CL, Maraganore DM, Bower JH, et al. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006; 21:446–455. [DOI] [PubMed] [Google Scholar]
  • 27.Bhattacharjee S, Sambamoorthi U. Co-occurring chronic conditions and health care expenditures associated with Parkinson's disease: a propensity score matched analysis. Parkinsonism Relat Disord 2013; 19:746–750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 2012; 71:520–530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Katus L, Shtilbans A. Perioperative management of patients with Parkinson's disease. Am J Med 2014; 127:275–280. [DOI] [PubMed] [Google Scholar]
  • 30.Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci 1998; 5:131–135. [PubMed] [Google Scholar]
  • 31.Easdown LJ, Tessler MJ, Minuk J. Upper airway involvement in Parkinson's disease resulting in postoperative respiratory failure. Can J Anaesth 1995; 42:344–347. [DOI] [PubMed] [Google Scholar]
  • 32.Monteiro L, Souza-Machado A, Valderramas S, et al. The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis. Clin Ther 2012; 34:1049–1055. [DOI] [PubMed] [Google Scholar]
  • 33.Yeo L, Singh R, Gundeti M, et al. Urinary tract dysfunction in Parkinson's disease: a review. Int Urol Nephrol 2012; 44:415–424. [DOI] [PubMed] [Google Scholar]
  • 34.Gerlach OH, Broen MP, van Domburg PH, et al. Deterioration of Parkinson's disease during hospitalization: survey of 684 patients. BMC Neurol 2012; 12:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lyons KE, Pahwa R. The impact and management of nonmotor symptoms of Parkinson's disease. Am J Manag Care 2011; 17:S308–S314. [PubMed] [Google Scholar]
  • 36.Hsu YT, Liao CC, Chang SN, et al. Increased risk of depression in patients with Parkinson disease: a nationwide cohort study. Am J Geriatr Psychiatry 2015; 23:934–940. [DOI] [PubMed] [Google Scholar]
  • 37.Trujillo-Santos J, Gussoni G, Gadelha T, et al. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism. Thromb Res 2014; 133:S29–S34. [DOI] [PubMed] [Google Scholar]
  • 38.Santiago JA, Potashkin JA. System-based approaches to decode the molecular links in Parkinson's disease and diabetes. Neurobiol Dis 2014; 72:84–91. [DOI] [PubMed] [Google Scholar]
  • 39.Winter Y, Balzer-Geldsetzer M, Spottke A, et al. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur J Neurol 2010; 17:1156–1163. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES